Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd cash flow reinvestment rate. Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow Reinvestment Rate of 0.48x as of September 2025, reinvesting CN¥56.87 Million (capex CN¥56.87 Million ) from operating cash flow of CN¥117.38 Million. See 600436 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Cash flow reinvestment rate of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. Historical reinvestment intensity for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 24 annual periods. Explore Zhangzhou Pientzehuang Pharmaceutical Co (600436) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2001–2025)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2001 to 2025. Year-by-year capital reinvestment analysis for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhangzhou Pientzehuang Pharmaceutical Co cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.00x | CN¥539.00 Million | CN¥77.03 Million | CN¥339.80 Million | ▲ +617.2% |
| 2024 | 0.98x | CN¥1.28 Billion | CN¥1.31 Billion | CN¥1.07 Billion | ▼ -3.0% |
| 2023 | 1.01x | CN¥2.22 Billion | CN¥2.21 Billion | CN¥141.87 Million | ▲ +8.9% |
| 2022 | 0.92x | CN¥6.35 Billion | CN¥6.87 Billion | CN¥175.37 Million | ▲ +81.2% |
| 2021 | 0.51x | CN¥235.49 Million | CN¥462.27 Million | CN¥92.17 Million | ▲ +72.2% |
| 2020 | 0.30x | CN¥434.05 Million | CN¥1.47 Billion | CN¥419.01 Million | ▲ +139.9% |
| 2018 | 0.12x | CN¥75.52 Million | CN¥612.31 Million | CN¥74.24 Million | ▼ -37.6% |
| 2017 | 0.20x | CN¥133.69 Million | CN¥676.93 Million | CN¥51.87 Million | ▼ -78.9% |
| 2016 | 0.94x | CN¥369.26 Million | CN¥394.54 Million | CN¥90.97 Million | ▲ +140.9% |
| 2015 | 0.39x | CN¥118.68 Million | CN¥305.51 Million | CN¥78.86 Million | ▲ +297.3% |
| 2014 | 0.10x | CN¥25.87 Million | CN¥264.50 Million | CN¥25.87 Million | ▼ -81.7% |
| 2013 | 0.53x | CN¥146.54 Million | CN¥274.34 Million | CN¥146.54 Million | ▼ -44.1% |
| 2012 | 0.96x | CN¥155.22 Million | CN¥162.40 Million | CN¥155.22 Million | ▲ +526.1% |
| 2011 | 0.15x | CN¥35.56 Million | CN¥232.95 Million | CN¥35.56 Million | ▼ -19.4% |
| 2010 | 0.19x | CN¥38.90 Million | CN¥205.41 Million | CN¥38.90 Million | ▼ -17.3% |
| 2009 | 0.23x | CN¥29.67 Million | CN¥129.52 Million | CN¥29.67 Million | ▼ -95.1% |
| 2008 | 4.65x | CN¥58.50 Million | CN¥12.57 Million | CN¥58.50 Million | ▲ +162.4% |
| 2007 | 1.77x | CN¥106.47 Million | CN¥60.04 Million | CN¥106.47 Million | ▲ +932.2% |
| 2006 | 0.17x | CN¥8.71 Million | CN¥50.70 Million | CN¥8.71 Million | ▼ -65.6% |
| 2005 | 0.50x | CN¥34.54 Million | CN¥69.06 Million | CN¥34.54 Million | ▲ +358.9% |
| 2004 | 0.11x | CN¥10.75 Million | CN¥98.67 Million | CN¥10.75 Million | ▼ -77.3% |
| 2003 | 0.48x | CN¥15.56 Million | CN¥32.36 Million | CN¥15.56 Million | ▲ +419.2% |
| 2002 | 0.09x | CN¥9.77 Million | CN¥105.45 Million | CN¥9.77 Million | ▼ -47.6% |
| 2001 | 0.18x | CN¥11.64 Million | CN¥65.84 Million | CN¥11.64 Million | — |